{
    "id": 29507,
    "fullName": "ERBB3 D581N",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "ERBB3 (HER3) D581N lies within the extracellular domain of the Erbb3 (Her3) protein (UniProt.org). D581N confers a gain of function on the Erbb3 (Her3) protein as demonstrated by increased downstream signaling, proliferation and colony formation in culture, and enhanced tumor growth in mouse models (PMID: 29954840).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 14332,
                    "pubMedId": 29954840,
                    "title": "Genomic ERBB2/ERBB3 mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29954840"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2065,
        "geneSymbol": "ERBB3",
        "terms": [
            "ERBB3",
            "c-erbB-3",
            "c-erbB3",
            "ErbB-3",
            "erbB3-S",
            "FERLK",
            "HER3",
            "LCCS2",
            "MDA-BF-1",
            "p180-ErbB3",
            "p45-sErbB3",
            "p85-sErbB3"
        ]
    },
    "variant": "D581N",
    "createDate": "03/01/2019",
    "updateDate": "03/07/2019",
    "referenceTranscriptCoordinates": {
        "id": 178875,
        "transcript": "NM_001982",
        "gDna": "chr12:g.56094438G>A",
        "cDna": "c.1741G>A",
        "protein": "p.D581N",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 16213,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Sapitinib (AZD8931) reduced downstream p-ERK and p-AKT signaling and cell viability in gallbladder carcinoma cell lines expressing ERBB3 (HER3) D581N and CD274 (PD-L1) in culture (PMID: 29954840).",
            "molecularProfile": {
                "id": 31588,
                "profileName": "CD274 pos ERBB3 D581N"
            },
            "therapy": {
                "id": 910,
                "therapyName": "Sapitinib",
                "synonyms": null
            },
            "indication": {
                "id": 4948,
                "name": "gallbladder carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 14332,
                    "pubMedId": 29954840,
                    "title": "Genomic ERBB2/ERBB3 mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29954840"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 31545,
            "profileName": "ERBB3 D581N",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 31588,
            "profileName": "CD274 pos ERBB3 D581N",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 178875,
            "transcript": "NM_001982",
            "gDna": "chr12:g.56094438G>A",
            "cDna": "c.1741G>A",
            "protein": "p.D581N",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}